A NEW COMBINATION FOR APPLICATION IN TREATMENT OF MALIGNANT NOVEL EDUCATION

摘要

The present application n relates to a pharmaceutical composition comprising a PD-1 antibody and an M-CSF antibody. The combination can be administered independently or separately, in a quantity which is therapeutically effective for the treatment of cancer.